NMRD - Nemaura Medical Inc Stock Price, Fair Value and News

Market Closed

NMRD Stock Valuation Analysis

Valuation

Max Portfolio %

NMRD Price Action

NMRD RSI Chart

NMRD Stock Valuation Analysis

Valuation

Max Portfolio %

NMRD Valuation

NMRD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NMRD Fundamentals

NMRD Revenue

NMRD Earnings

NMRD Profitability

NMRD Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	397.3K	0	0	0
2022	503.9K	0	542.4K	581.0K
2021	0	0	0	380.7K
2020	257.4K	0	0	0
2019	23.9K	19.0K	11.0K	134.2K
2018	88.5K	72.4K	56.2K	40.1K

Get all data in R, Python etc through our Historical Stock Data APIs

About Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

CEO	Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
WEBSITE	https://nemauramedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	36